What Is GLP-1 Medication? A Physician's Guide to How These Drugs Actually Work

What Is GLP-1 Medication? A Physician's Guide to How These Drugs Actually Work

By Dr. Onikepe Adegbola, MD PhD

GLP-1 medication has become one of the most talked-about drug classes in modern medicine — and also one of the most misunderstood. Patients come into my office asking about "the Ozempic shot" without knowing that Ozempic is just one brand in a family of medications that work through a specific hormonal pathway. Understanding what GLP-1 medication actually does, and how it differs from older weight loss drugs, changes how you approach treatment.

So what is GLP-1 medication? These are drugs that mimic or enhance a naturally occurring gut hormone called glucagon-like peptide-1. Your body already makes GLP-1 every time you eat. The medications simply amplify its effects — and the results, for the right patients, have been remarkable.

The Biology Behind GLP-1: What Your Body Already Does

To understand what GLP-1 medication does, you need to understand the hormone it's based on. GLP-1 (glucagon-like peptide-1) is an incretin hormone produced by L-cells in your small intestine. When food hits your gut, these cells release GLP-1 into your bloodstream.

Natural GLP-1 does several things simultaneously:

• Stimulates insulin release from the pancreas in a glucose-dependent manner (meaning it only triggers insulin when blood sugar is elevated, which reduces hypoglycemia risk)
• Suppresses glucagon, the hormone that tells your liver to dump stored sugar into your blood
• Slows gastric emptying, keeping food in your stomach longer so you feel full
• Signals the brain through receptors in the hypothalamus and brainstem, reducing appetite at a neurological level

The catch: natural GLP-1 has a half-life of about 2 minutes. Your body breaks it down almost immediately through an enzyme called DPP-4. GLP-1 medications are engineered to resist that breakdown. Semaglutide, for example, has a half-life of approximately 7 days. That's why one weekly injection can produce sustained effects.

Why This Mechanism Matters

Older weight loss medications — phentermine, for example — worked primarily as stimulants. They ramped up norepinephrine to suppress appetite through sheer neurochemical force. The side effect profiles reflected this: elevated heart rate, insomnia, dependency risk.

GLP-1 medication works differently. It works through your body's own satiety system. Patients on these drugs don't describe white-knuckling through hunger. They describe the absence of food noise — that constant background chatter about what to eat next. For people who have struggled with appetite regulation their entire lives, this feels like a fundamental shift, not a temporary suppression.

The Major GLP-1 Medications Available Today

When people ask "what is GLP-1 medication," they're usually asking about a specific drug they've heard of. Here's what's currently available:

Semaglutide

The most well-known molecule in the class. Available as:

• Ozempic — injectable semaglutide approved for type 2 diabetes (0.25 mg to 2.0 mg weekly)
• Wegovy — injectable semaglutide approved for chronic weight management (up to 2.4 mg weekly)
• Rybelsus — oral semaglutide for type 2 diabetes (3 mg, 7 mg, 14 mg daily tablets)

The STEP trial program demonstrated average weight loss of approximately 15–17% of body weight with Wegovy over 68 weeks. Semaglutide also showed a 20% reduction in major cardiovascular events in the SELECT trial — a finding that expanded its clinical significance well beyond weight loss.

Tirzepatide

A dual GIP/GLP-1 receptor agonist — it targets two incretin pathways rather than one. Available as:

• Mounjaro — approved for type 2 diabetes (2.5 mg to 15 mg weekly)
• Zepbound — approved for chronic weight management (same molecule, same doses)

The SURMOUNT trials showed tirzepatide producing average weight loss of 18–22% of body weight at the highest dose over 72 weeks. This makes it the most effective GLP-1 medication for weight loss currently available, though head-to-head comparisons with semaglutide are limited.

Liraglutide

• Victoza — for type 2 diabetes (daily injection)
• Saxenda — for chronic weight management (daily injection up to 3.0 mg)

Liraglutide was the first GLP-1 approved for weight management but produces more modest results (approximately 5–8% body weight loss). It requires daily injections, which many patients find burdensome compared to weekly semaglutide or tirzepatide.

Dulaglutide (Trulicity)

Approved only for type 2 diabetes. Weekly injection. Commonly prescribed but not FDA-approved for weight management. Weight loss with dulaglutide is modest — typically 3–5% of body weight.

What GLP-1 Medication Does in Practice: Beyond the Clinical Trials

Clinical trials tell you averages. In my practice, I see the individual variation that averages obscure. Some observations from prescribing GLP-1 medication to hundreds of patients:

The appetite effect is real, but it's not the whole story. Most patients notice reduced hunger within the first 2–4 weeks of treatment. But the deeper change — reduced food reward signaling, fewer cravings, less emotional eating — often takes 6–8 weeks to fully develop. Patients who abandon treatment at 4 weeks because "it's not working" often haven't given the medication enough time.

GI side effects are the main barrier. Nausea, constipation, bloating, and changes in bowel habits affect a majority of patients at some point during treatment. These effects tend to peak after dose escalation and improve within 1–2 weeks. But for a subset of patients, particularly those with pre-existing IBS or FODMAP sensitivities, the GI impact can be persistent enough to threaten adherence.

This is why I often recommend Casa de Sante GLP-1 supplements to my patients starting these medications. Digestive enzymes formulated for GLP-1 patients can help manage the bloating and nutrient absorption issues that come with slower gastric emptying. A daily vitamin and mineral complex fills the nutritional gaps that reduced food intake creates. And a gut-friendly protein supplement ensures muscle preservation even when appetite is minimal.

Weight loss patterns are not linear. I see patients who lose 8 pounds in month one, then nothing in month two, then 5 pounds in month three. Plateaus are normal and expected. They do not mean the medication has stopped working. Body composition changes (losing fat while gaining or maintaining muscle) often continue even when the scale isn't moving.

Who Is a Candidate for GLP-1 Medication?

Not everyone qualifies, and not everyone should use these drugs. Current FDA-approved criteria vary by indication:

For type 2 diabetes: GLP-1 medications are approved as adjunct therapy (alongside diet and exercise) for adults with type 2 diabetes. Several are now recommended as first-line or second-line treatments in ADA guidelines.

For chronic weight management: Semaglutide (Wegovy) and tirzepatide (Zepbound) are approved for adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, cardiovascular disease).

Who should not take GLP-1 medication:

• Anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Patients with a history of pancreatitis (use with extreme caution)
• Pregnant or breastfeeding women
• Patients with severe gastroparesis

Frequently Asked Questions

How long do you need to stay on GLP-1 medication?

Current evidence suggests GLP-1 medication for weight management should be treated as long-term therapy. The STEP 1 extension trial showed that patients who discontinued semaglutide regained approximately two-thirds of lost weight within one year. This doesn't mean you're "on it forever" necessarily — but stopping should be a planned, monitored decision, not an impulse.

Are GLP-1 medications safe long-term?

Semaglutide and liraglutide have been used clinically for over a decade with strong safety profiles. The SELECT trial followed semaglutide patients for over 3 years and found cardiovascular benefit, not harm. Long-term data for tirzepatide is still accumulating but early signals are consistent. That said, any medication used indefinitely warrants ongoing monitoring — which is why regular follow-up with your prescriber matters.

What is GLP-1 medication's most common side effect?

Nausea. It's dose-dependent, usually worst during dose escalation, and improves for most patients within 1–2 weeks of each dose increase. Constipation, diarrhea, and bloating are also common. Serious side effects — pancreatitis, gallbladder disease, thyroid tumors (in rodent models) — are rare but warrant awareness.

Can you take GLP-1 medication as a pill instead of an injection?

Currently, Rybelsus (oral semaglutide) is the only FDA-approved oral GLP-1 medication, and it's approved for type 2 diabetes, not weight management. Oral semaglutide for weight management (at a higher dose) has completed clinical trials and is expected to receive approval. Other oral GLP-1 formulations are in development.

Do GLP-1 medications cause muscle loss?

Rapid weight loss from any cause — surgery, caloric restriction, or medication — involves some lean mass loss alongside fat loss. The STEP trials showed that roughly 25–40% of weight lost was lean mass, which is consistent with non-surgical weight loss in general. Adequate protein intake (0.8–1.2 g per pound of lean body mass) and resistance exercise can minimize this significantly.